Trial Profile
Botulinum Toxin Type A for Injection of Bilateral Upper Extremity Tremor in Patients With Essential Tremor Using Kinematic Assessment
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 06 Jun 2022
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Essential tremor
- Focus Therapeutic Use
- 18 Jun 2020 Planned primary completion date changed from 1 Feb 2020 to 1 Sep 2020.
- 24 Apr 2019 Planned primary completion date changed from 1 Feb 2019 to 1 Feb 2020.
- 01 Oct 2018 Planned End Date changed from 1 Dec 2020 to 1 Dec 2021.